Leslie Global Wealth’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$751K Buy
2,983
+44
+1% +$9.47K 0.29% 38
2026
Q1
$639K Sell
2,939
-455
-13% -$101K 0.34% 33
2025
Q4
$775K Sell
3,394
-497
-13% -$113K 0.35% 29
2025
Q3
$901K Buy
3,891
+43
+1% +$8.76K 0.42% 28
2025
Q2
$714K Buy
3,848
+515
+15% +$95.7K 0.38% 31
2025
Q1
$698K Buy
3,333
+72
+2% +$14K 0.34% 33
2024
Q4
$579K Buy
3,261
+16
+0.5% +$2.94K 0.27% 39
2024
Q3
$641K Buy
3,245
+85
+3% +$15.9K 0.31% 35
2024
Q2
$542K Buy
+3,160
New +$523K 0.32% 34

Other funds holding ABBV

Leslie Global Wealth's ABBV Position: Q2 2026 in Review

Leslie Global Wealth increased its AbbVie (ABBV) stake by 1.5% in Q2 2026, buying an estimated $9.47K and bringing the position to 2,983 shares worth $751K. The position accounts for 0.29% of the portfolio, ranked #38.

Leslie Global Wealth first reported a position in ABBV in Q2 2024 and has held it in 9 quarters since. The position peaked at $901K in Q3 2025. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Leslie Global Wealth held 2,983 shares of AbbVie worth $751K as of Q2 2026.
  • Leslie Global Wealth bought 44 AbbVie shares in Q2 2026, an estimated $9.47K.
  • AbbVie made up 0.29% of Leslie Global Wealth's portfolio in Q2 2026, its #38 holding.
  • Leslie Global Wealth first reported a position in AbbVie in Q2 2024 and has held it in 9 quarters since.
  • Leslie Global Wealth's AbbVie position peaked at $901K in Q3 2025.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Leslie Global Wealth's 13F filing for Q2 2026, filed 21 Jul 2026.